12 and older, any sex, with Siblings or Childhood Cancer. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Child Posttraumatic Stress Disorder Symptom Scale for DSM-5Primary· Within 2 weeks post-intervention, data were collected over a period of up to 4 weeks
The Child PTSD Symptom Scale for DSM-5 (CPSS-V) \[citation\] is a 27-item measure of posttraumatic stress. Strong test-retest reliability, internal consistency, and convergent validity with other child PTSD measures have been established. This survey was administered only to sibling participants. Measure was scored by a total summation, scores may range from 0 to 80.
\*Higher scores reflect higher levels of post-traumatic stress symptoms
Group
Value
95% CI
SibACCESS (Sibling Participants)
15.3
± 3.5
Strengths & Difficulties Questionnaire (SDQ)Secondary· Within 2 weeks post-intervention, data were collected over a period of up to 4 weeks
The Strengths \& Difficulties Questionnaire (Goodman, 1997) is a 25-item measure of children's psychosocial adjustment. It has five scales: Emotional Symptoms, Conduct Symptoms, Hyperactivity/ Inattention Symptoms, Peer Relationship Problems, and Prosocial Behavior. Adapted versions were given to sibling (self-report) and parent (parent-report) participants. Measure was scored by a total summation reflecting total child difficulties, scores may range from 0-40.
\*Higher scores reflect worse child difficulties
Group
Value
95% CI
SibACCESS (Sibling Participants)
16.3
± 5.5
SibACCESS (Parent Participants)
13.0
± 2.8
Sibling Perception Questionnaire (SPQ)Secondary· Within 2 weeks post-intervention, data were collected over a period of up to 4 weeks
The Sibling Perception Questionnaire (SPQ) evaluates group interventions for siblings and parents designed to increase sibling understanding of and adjustment to chronic illness and developmental disability (CI/DD). Present measure was adapted from Sahler \& Carpenter (1989) and Lobato \& Kao (2002) versions to reflect cancer-related topics and create a parent-report version. Siblings and parents completed Sibling-report and Parent-report versions respectively. Measure was scored by a total summation, scores may range from 18 to 72.
\*Higher scores reflect more negative sibling adjustment
Group
Value
95% CI
SibACCESS (Sibling Participants)
24.7
± 13.9
SibACCESS (Parent Participants)
36.5
± 6.4
Coping Self-efficacy ScaleSecondary· Within 2 weeks post-intervention, data were collected over a period of up to 4 weeks
The Coping self-efficacy scale (Chesney et. al, 2006) was used to assess participants' confidence in performing coping behaviors when faced with life challenges. This measure was only used with sibling participants. Measure was scored by a total summation, scores may range from 0 to 260.
\*Higher scores reflect higher levels of coping self-efficacy
Group
Value
95% CI
SibACCESS (Sibling Participants)
188.0
± 46.0
Emotional Avoidance Strategy Inventory For AdolescentsSecondary· Within 2 weeks post-intervention, data were collected over a period of up to 4 weeks
The Emotional Avoidance Strategy Inventory for Adolescents (Kennedy \& Ehrenreich-May, 2017) is a 17-item measure of emotional avoidance with acceptable psychometrics. Measure was scored by a total summation, scores may range from 0-68.
Group
Value
95% CI
SibACCESS (Sibling Participants)
11.7
± 12.0
Perceived Filial Self-Efficacy ScaleSecondary· Within 2 weeks post-intervention, data were collected over a period of up to 4 weeks
The Perceived Filial Self-Efficacy Scale (PFSES) (Caprara et. al, 2004) is a 16-item measure that assess efficacy beliefs that family members hold about their role as spouse, parent, and child, as well as about the functioning of family as a holistic system. This survey was administered only to sibling participants. Measure was scored by a total summation, scores may range from 16 to 112.
\*Higher scores reflect better efficacy beliefs
Group
Value
95% CI
SibACCESS (Sibling Participants)
89.7
± 16.0
Sibling Cancer Needs Inventory (SCNI)Secondary· Within 2 weeks post-intervention, data were collected over a period of up to 4 weeks
The Sibling Cancer Needs Inventory (SCNI) (Patterson et. al, 2014) is a 45 item measure that assesses psychosocial needs of siblings are established to assist in the provision of appropriate support. This survey was administered only to sibling participants. The overall SCNI score are determined by summing the responses to all items, giving a possible range of SCNI scores from 45 to 180.
\*Higher scores reflect higher sibling psychosocial needs
Group
Value
95% CI
SibACCESS (Sibling Participants)
68.7
± 15.5
Acceptability of ProgramSecondary· Within 2 weeks post-intervention, data were collected over a period of up to 4 weeks
Based from the Client Satisfaction Questionnaire (Roberts et. el, 1984), this measure assesses participants general acceptability of the SibACCESS intervention. Measure was scored by a total summation, scores may range from 0 to 52.
\*Higher scores reflect higher levels of acceptability
Group
Value
95% CI
SibACCESS (Sibling Participants)
40.0
± 7.0
SibACCESS (Parent Participants)
40.0
± 11.3
Sponsor's own description
This study aims to address barriers to psychosocial care for siblings of children with cancer by piloting a group-based telehealth program for adolescent siblings of youth with cancer. The pilot trial will be preceded by a treatment development stage during which study staff will interview English- and Spanish-speaking families and psychosocial providers to assess preferences for program content, format, timing, and cultural feasibility and acceptability, while considering ideas to minimize participation barriers. Information from interviews will inform any revisions to the proposed pilot program. Then, the new SibACCESS program will be tested with a small group of families located in Massachusetts, Delaware, or Rhode Island using video-teleconferencing technology. Families will complete exit interviews to assess program acceptability and perceived benefits.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
NCT06854822 — Siblings to a Child with Cancer: Needs and Pre-loss Grief
· recruiting
Other Boston University Charles River Campus trials
Trials by the same sponsor.
NCT07461584 — Memory Enhancement in Aging With Optimal Dosing
· EARLY_PHASE1
· not yet recruiting
NCT07208318 — Restructuring the Alpha-Gamma Code in Aging Vision
· EARLY_PHASE1
· not yet recruiting
NCT06182241 — Identifying and Addressing Barriers to Retention in the Cervical Cancer Treatment Cascade Among Women With HIV in South
· NA
· not yet recruiting
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Boston University Charles River Campus
Last refreshed: 17 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04889755.